FIGO Stage IIIA Ovarian Cancer
1 clinical trials · Condition
◉ Watch FIGO Stage IIIA Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer (NCT01097746) | M.D. Anderson Cancer Center | 2010-04-14 |
Track FIGO Stage IIIA Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.